TERUMO CORPORATION Funds and ETFs Terumo Corporation
Equities
4543
JP3546800008
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,663 JPY | +0.15% |
|
+1.64% | +15.23% |
| 04-12 | Penumbra, Inc. : The underdog in healthcare |  |
| 03-18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
ETFs positioned on Terumo Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 31 M€ | +13.91% | ||
| 1.94% | 31,732 M€ | +15.18% | - | |
| 1.93% | 1,198 M€ | +14.37% | - | |
| 1.90% | 16,729 M€ | +14.33% | - | |
| 1.82% | 67,864 M€ | +15.20% | ||
| 1.42% | 251 M€ | +13.17% | ||
| 1.27% | 174 M€ | -.--% | - | |
| 1.27% | 51 M€ | -.--% | - | |
| 1.23% | 15 M€ | +16.04% | ||
| 0.97% | 16 M€ | -5.09% | ||
| 0.87% | 81 M€ | +15.99% | ||
| 0.86% | 11 M€ | +13.64% | - | |
| 0.79% | 73 M€ | +18.87% | ||
| 0.63% | 14 M€ | +18.73% | ||
| 0.58% | 60 M€ | +16.25% | ||
| 0.58% | 10,207 M€ | +16.36% | ||
| 0.58% | 5,115 M€ | +16.14% | ||
| 0.56% | 26 M€ | +21.71% | ||
| 0.54% | 18 M€ | +16.15% | - | |
| 0.42% | 66,066 M€ | +16.86% | - | |
| 0.42% | 144,586 M€ | +16.55% | ||
| 0.42% | 20,721 M€ | +15.40% | - | |
| 0.41% | 717 M€ | +5.79% | ||
| 0.34% | 26 M€ | +1.54% | - | |
| 0.28% | 29 M€ | +8.37% | - | |
| 0.28% | 4 M€ | -.--% | - | |
| 0.24% | 2 M€ | -.--% | - | |
| 0.24% | 2 M€ | +9.19% | - | |
| 0.23% | 36 M€ | +1.05% | - | |
| 0.13% | 21 M€ | +0.27% | - | |
| 0.11% | 10 M€ | -3.35% | - |
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,659
JPY
Average target price
2,951
JPY
Spread / Average Target
+10.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.23% | 25.05B | |
| -3.43% | 184B | |
| -1.81% | 107B | |
| -4.15% | 67.52B | |
| +1.43% | 50.06B | |
| +11.60% | 45.67B | |
| +3.40% | 41B | |
| +3.03% | 26.73B | |
| +3.21% | 26.47B | |
| -1.76% | 24.56B |
- Stock Market
- Equities
- 4543 Stock
- Funds and ETFs Terumo Corporation
